SEC 13F Intelligence

Managers / Q4 2022 · view latest →

Informed Momentum Co LLC

CIK 0001510989 · 215 HIGHWAY 101, SUITE 216, SOLANA BEACH, CA, 92075 · 7604795075

Reported Value
$483M
Q4 2022
Positions
249
Filings on Record
31
2019–present window
Filed
Feb 14, 2023
original filing

Summary

Informed Momentum Co LLC reported $483M in U.S.-listed holdings across 249 positions for Q4 2022.

Its largest position, ADMA, represents 1.4% of the portfolio.

Compared with Q3 2022, the fund opened 132 new positions and exited 129.

Portfolio Metrics

Turnover
+51.3%
vs prior filed quarter
Top-10 Concentration
+9.9%
share of reported value
Largest Position
+1.4%
Adma Biologics
New / Exited
132 / 129
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $368MQ4 ’18Q1 ’19: $408MQ2 ’19: $409MQ3 ’19: $378MQ4 ’19: $455MQ4 ’19Q1 ’20: $322MQ2 ’20: $452MQ3 ’20: $422MQ4 ’20: $611MQ4 ’20Q1 ’21: $664MQ2 ’21: $648MQ3 ’21: $593MQ4 ’21: $610MQ4 ’21Q1 ’22: $537MQ2 ’22: $410MQ3 ’22: $460MQ4 ’22: $483MQ4 ’22Q1 ’23: $454MQ2 ’23: $540MQ3 ’23: $518MQ4 ’23: $564MQ4 ’23Q1 ’24: $642MQ2 ’24: $615MQ3 ’24: $669MQ4 ’24: $706MQ4 ’24Q1 ’25: $578MQ2 ’25: $660MQ3 ’25: $872MQ4 ’25: $898MQ4 ’25Q1 ’26: $866Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 90.9%Other: 9.1%
  • Common Stock · 90.9% · $439M
  • Other · 9.1% · $44M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
VKTXViking Therapeutics IncNEW+494.9K494.9K+$5M$5M
PDSBPDS Biotechnology CorpNEW+330.4K330.4K+$4M$4M
KLXEKLX Energy Services Holdings IncNEW+234.9K234.9K+$4M$4M
PARRPar Pacific Holdings IncNEW+142.3K142.3K+$3M$3M
TDWTidewater IncNEW+89.0K89.0K+$3M$3M
Weatherford International PLCNEW+62.3K62.3K+$3M$3M
BBWBuild-A-Bear Workshop IncNEW+133.0K133.0K+$3M$3M
PCVXVaxcyte IncNEW+64.8K64.8K+$3M$3M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2022

50 positions
#IssuerClass% PortfolioValueShares
1ADMAADMA Biologics Inchistory →Common Stock1.41%$7M1.75M
2UFPTUFP Technologies Inchistory →Common Stock1.21%$6M49.7K
3RYTMRhythm Pharmaceuticals IncCommon Stock0.99%$5M164.7K
4VKTXViking Therapeutics IncCommon Stock0.96%$5M494.9K
5THTDR Capital LLPCommon Stock0.95%$5M304.0K
6PDSBPDS Biotechnology CorpCommon Stock0.90%$4M330.4K
7DGIIDigi International IncCommon Stock0.89%$4M117.7K
8CECOCECO Environmental CorpCommon Stock0.88%$4M364.0K
9KLXEKLX Energy Services Holdings IncCommon Stock0.84%$4M234.9K
10ACLXGBXArcellx IncCommon Stock0.82%$4M128.5K
11AGYSAgilysys IncCommon Stock0.82%$4M50.0K
12MGPIMGP Ingredients IncCommon Stock0.81%$4M37.0K
13PIImpinj IncCommon Stock0.81%$4M35.7K
14DXLGDestination XL Group IncCommon Stock0.76%$4M542.3K
15TMDXTransMedics Group IncCommon Stock0.74%$4M57.9K
16ETNBGBP89bio IncCommon Stock0.73%$4M275.9K
17HDSNHudson Technologies IncCommon Stock0.73%$4M346.3K
18Cymabay Therapeutics IncCommon Stock0.71%$3M550.5K
19HROWHarrow Health IncCommon Stock0.71%$3M232.9K
20BELFBBel Fuse IncCommon Stock0.71%$3M104.3K
21RELLRichardson Electronics Ltd/United StatesCommon Stock0.70%$3M159.7K
22ELFelf Beauty IncCommon Stock0.70%$3M60.9K
23HURNHuron Consulting Group IncCommon Stock0.70%$3M46.3K
24Prometheus Biosciences IncCommon Stock0.69%$3M30.5K
25AEHRAehr Test SystemsCommon Stock0.69%$3M165.1K
26PARRPar Pacific Holdings IncCommon Stock0.68%$3M142.3K
27TDWTidewater IncCommon Stock0.68%$3M89.0K
28GFFGriffon CorpCommon Stock0.67%$3M91.1K
29EXTRExtreme Networks IncCommon Stock0.67%$3M176.4K
30Prothena Corp PLCCommon Stock0.67%$3M53.3K
31Weatherford International PLCCommon Stock0.66%$3M62.3K
32BBWBuild-A-Bear Workshop IncCommon Stock0.66%$3M133.0K
33PCVXVaxcyte IncCommon Stock0.64%$3M64.8K
34EZPWEZCORP IncCommon Stock0.64%$3M378.9K
35CTVHelix Energy Solutions Group IncCommon Stock0.64%$3M415.7K
36POWLPowell Industries IncCommon Stock0.63%$3M86.5K
37UAOSterling Infrastructure IncCommon Stock0.62%$3M91.9K
38MODModine Manufacturing CoCommon Stock0.62%$3M151.5K
39ATENA10 Networks IncCommon Stock0.61%$3M178.2K
40MODNEURModel N IncCommon Stock0.61%$3M72.8K
41AKROAkero Therapeutics IncCommon Stock0.61%$3M53.5K
42PRVBUSDProvention Bio IncCommon Stock0.60%$3M276.3K
43VRDNViridian Therapeutics IncCommon Stock0.60%$3M99.6K
44CBZCBIZ IncCommon Stock0.59%$3M61.3K
45Scorpio Tankers IncCommon Stock0.59%$3M52.9K
46LYTSLSI Industries IncCommon Stock0.58%$3M227.0K
47DNOWNOW IncCommon Stock0.57%$3M218.0K
48SNEXStoneX Group IncCommon Stock0.57%$3M29.0K
49CN2Catalyst Pharmaceuticals IncCommon Stock0.57%$3M148.3K
50FSSFederal Signal CorpCommon Stock0.57%$3M59.1K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$866M273May 13, 202613F-HRchanges · EDGAR ↗
Q4 2025$898M268Feb 12, 202613F-HRchanges · EDGAR ↗
Q3 2025$872M254Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$660M220Aug 12, 202513F-HRchanges · EDGAR ↗
Q1 2025$578M246May 13, 202513F-HRchanges · EDGAR ↗
Q4 2024$706M251Feb 13, 202513F-HRchanges · EDGAR ↗
Q3 2024$669M239Nov 13, 202413F-HRchanges · EDGAR ↗
Q2 2024$615M241Aug 12, 202413F-HRchanges · EDGAR ↗
Q1 2024$642M231May 13, 202413F-HRchanges · EDGAR ↗
Q4 2023$564M232Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$518M271Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$540M256Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$454M248May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$483M249Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$460M246Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$410M245Aug 12, 202213F-HRchanges · EDGAR ↗
Q1 2022$537M270May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$610M279Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$593M274Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$648M302Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$664M322May 11, 202113F-HRchanges · EDGAR ↗
Q4 2020$611M292Feb 11, 202113F-HRchanges · EDGAR ↗
Q3 2020$422M263Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$452M254Aug 13, 202013F-HRchanges · EDGAR ↗
Q1 2020$322M205May 13, 202013F-HRchanges · EDGAR ↗
Q4 2019$455M242Feb 11, 202013F-HRchanges · EDGAR ↗
Q3 2019$378M229Nov 13, 201913F-HRchanges · EDGAR ↗
Q2 2019$409M242Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$408M248May 13, 201913F-HRchanges · EDGAR ↗
Q4 2018$368M248Feb 13, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 1 additional manager.

  • Bank of New York Mellon Corporation028-12592

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.